Breastfeeding recommendations for women taking anti-seizure medications.

Autor: Al-Faraj AO; Boston Medical Center, Boston University School of Medicine, United States. Electronic address: alfaraj@bu.edu., Pang TD; Beth Israel Deaconess Medical Center, Harvard Medical School, United States. Electronic address: tpang@bidmc.harvard.edu.
Jazyk: angličtina
Zdroj: Epilepsy & behavior : E&B [Epilepsy Behav] 2022 Nov; Vol. 136, pp. 108769. Date of Electronic Publication: 2022 Jun 08.
DOI: 10.1016/j.yebeh.2022.108769
Abstrakt: The literature regarding breastfeeding and effects of anti-seizure medication (ASM) exposure on the breastfed infant has been evolving rapidly over the last decade as new studies advance our understanding of the extent of medication exposure via breastfeeding and the long-term developmental outcomes of breastfed infants. Currently, strong evidence supports the safety of breastfeeding for women with epilepsy (WWE) taking most prescribed ASMs. In this review, we present a comprehensive overview of the data regarding ASM exposure in breastfed infants and neurodevelopmental outcomes in breastfed infants of mothers taking various ASMs. In addition, we present current breastfeeding recommendations and the reported adverse effects of various ASMs to facilitate decision making in the clinical care of WWE.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2022 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: